Kamada (NASDAQ:KMDA) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Kamada (NASDAQ:KMDA – Free Report) in a research report released on Sunday morning. The firm issued a buy rating on the biotechnology company’s stock. Several other research firms have also weighed in on KMDA. HC Wainwright reiterated a buy rating and set a $11.00 price objective on shares of […]

Leave a Reply

Your email address will not be published.

Previous post Minerva Neurosciences (NASDAQ:NERV) Research Coverage Started at StockNews.com
Next post Comparing NB Bancorp (NASDAQ:NBBK) and Berkshire Hills Bancorp (NYSE:BHLB)